Parfezine
Brand names,
Parfezine
Analogs
Parfezine
Brand Names Mixture
Parfezine
Chemical_Formula
C19H24N2S
Parfezine
RX_link
No information avaliable
Parfezine
fda sheet
Parfezine
msds (material safety sheet)
Parfezine
Synthesis Reference
No information avaliable
Parfezine
Molecular Weight
312.473 g/mol
Parfezine
Melting Point
64.5 oC
Parfezine
H2O Solubility
0.693 mg/L
Parfezine
State
Solid
Parfezine
LogP
5.772
Parfezine
Dosage Forms
Tablet (10 mg); Tablet (scored, 50 mg)
Parfezine
Indication
For use in the treatment of Parkinson's disease and also used to control severe reactions to certain medicines such as reserpine.
Parfezine
Pharmacology
Ethopropazine, a phenothiazine and antidyskinetic, is used in the treatment of Parkinson's disease. By improving muscle control and reducing stiffness, this drug permits more normal movements of the body as the disease symptoms are reduced. It is also used to control severe reactions to certain medicines such as reserpine, phenothiazines, chlorprothixene, thiothixene, loxapine, and haloperidol. Unlike other NMDA antagonists, ethopropazine — because of its anticholinergic action — is largely devoid of neurotoxic side effects. Ethopropazine also has a slight antihistaminic and local anesthetic effect.
Parfezine
Absorption
Well-absorbed from the gastrointestinal tract.
Parfezine
side effects and Toxicity
Symptoms of overdose include severe clumsiness or unsteadiness, severe drowsiness, severe dryness of mouth, nose, or throat, fast heartbeat, shortness of breath or troubled breathing, and warmth, dryness, and flushing of skin.
Parfezine
Patient Information
Parfezine
Organisms Affected
Humans and other mammals